Computational methods can lead to better vaccines faster

The review article proposes a strategy for effective and efficient COVID-19 vaccine design.

5:00 AM

Author | Kelly Malcom

covid cell lab note
Jacob Dwyer, Justine Ross, Michigan Medicine

Since the onset of the coronavirus pandemic in late 2019, more than 100 COVID-19 vaccines have entered or completed clinical trials, many of which have been authorized to be used around the world. However, fighting the ever-increasing threat posed by new SARS-CoV-2 variants calls for more efficient ways of developing safe and effective vaccines for COVID-19—and other emerging infectious diseases.

Anthony Huffman, Ph.D., of the Department of Computational Medicine and Bioinformatics, Yongqun Oliver He, Ph.D., and their colleagues at the University of Michigan Medical School recently published a review article in the journal Briefings in Bioinformatics that systematically surveys various methods in so-called rational COVID-19 vaccine design—which uses IT to determine potential vaccine targets—and proposes a strategy for effective and efficient COVID-19 vaccine design.

They classified three major stages in computational vaccine design:

  • Identification of experimentally verified gold standard protective antigens—the proteins that trigger the immune system to mount a defense—through literature mining

  • Rational vaccine design using reverse vaccinology, which uses the virus' RNA or DNA to identify proteins that could be targets for vaccines and structural vaccinology, which uses the atomic structure of a virus to inform potential vaccines—using the gold standard data

  • And further improvement of vaccine design through the surveillance and application of the approved vaccine successes and adverse event reports.

The team developed Protegen, a database of experimentally verified protective antigens, which can be used as gold standard data for rational vaccine design. With the support of various machine learning methods, many RV and SV approaches have been developed and applied to COVID-19 vaccine design.

As an example of COVID-19 vaccine design, Edison Ong, Ph.D., and his teammates in the He laboratory have developed and applied RV and machine learning methods to successfully predict the SARS-CoV-2 Spike (S) protein as the best viral protein for COVID-19 vaccine development, which is aligned with the current usage of mRNA of the S protein in Pfizer and Moderna vaccines.

Furthermore, the team also unveiled several other viral proteins valuable for COVID-19 vaccine development and proposed a new cocktail vaccine recipe to possibly increase the efficacy and safety of next-generation COVID-19 vaccines.

Papers cited:

Anthony Huffman*, Edison Ong*, Junguk Hur, Adonis D'Mello, Hervé Tettelin, Yongqun He. COVID-19 Vaccine Design Using Reverse and Structural Vaccinology, Ontology-based Literature Mining, and Machine Learning. Briefings in Bioinformatics. DOI: 10.1093/bib/bbac190. PMID:35649389

Ong E, Wong M, Huffman A, He Y. COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. Frontiers in Immunology. DOI: 10.3389/fimmu.2020.0158


More Articles About: Industry DX Basic Science and Laboratory Research Covid-19 Community Health All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories white pills falling out of orange pill bottle on a brown surface
Health Lab
Drug combination reduces breast cancer risk and improves metabolic health in rats
Researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.
RNA strand in purple on black background
Health Lab
A structural biologist weighs in on the tricky task of determining RNA’s shape
A recent article in Nature details why the quest to determine the shapes of RNA is difficult even for artificial intelligence.
mouse seeing three cookies with red dots out of brain
Health Lab
Researchers use nanoparticles to target glioblastoma in mice
University of Michigan researchers have created nanodiscs that can target cholesterol levels in GBM, starving the cancer cells and increasing survival rates of the treated mice.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.
doctors drawn looking at big oversized lungs
Health Lab
The most effective prevention method for complications post lung transplant
Out of the two most common treatments for chronic lung allograft dysfunction, a condition that can form after lung transplantation that has no treatment, a study from University of Michigan Health found that cyclosporine is not as effective as tacrolimus in preventing the condition.
Michigan Medicine Presents... on dark blue background with two lights shining on the words
Michigan Medicine Presents
Episode 1: The Science of Bipolar Disorder
Bipolar disorder is more than just mood swings. It’s a journey marked by intense highs of mania and debilitating lows of depression. But within this condition exist millions of people who live unique lives. Today, we're going to talk to three clinical and research experts from the Heinz C. Prechter Bipolar Research Program at Michigan Medicine to learn more about the science of bipolar disorder—diagnostics, genetics, and decision-making. We'll be hearing from Dr. Melvin McInnis, director of the Prechter Program, Dr. Paul Jenkins, associate professor of pharmacology and associate director of the Prechter Program, and Dr. Chandra Sripada, professor of psychiatry and philosophy.